Taiwan FDA registration 76ff9e7f02457d42d22e1817216ba8d7
"RANDOX" RIQAS Glycated Haemoglobin (HbA1c) Programme (Non-Sterile)
TW: "倫多士" 糖化血色素分析院外品管計劃 (未滅菌)
Taiwan·Risk Class 1·MD·RANDOX LABORATORIES LTD.·Registered Dec 22, 2016 – Dec 22, 2021ExpiredRegistration details
- Analysis ID
- 76ff9e7f02457d42d22e1817216ba8d7
- License Form
- Ministry of Health Medical Device Import No. 017327
- Customs Code
- DHA09401732707
Company information
- Manufacturer
- RANDOX LABORATORIES LTD.
- Manufacturer Country
- United Kingdom
- Authorized Representative
- SCN TRADING COMPANY LIMITED
Product details
- Intended Use
- Limited to the first level identification range of quality control materials (analytical and non-analytical) (A.1660) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Dec 22, 2016
- Expiry Date
- Dec 22, 2021
About this record
Access comprehensive regulatory information for "RANDOX" RIQAS Glycated Haemoglobin (HbA1c) Programme (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 76ff9e7f02457d42d22e1817216ba8d7 and manufactured by RANDOX LABORATORIES LTD.. The authorized representative in Taiwan is SCN TRADING COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices